• 제목/요약/키워드: Secondary malignant neoplasms

검색결과 9건 처리시간 0.033초

Effects of Radiotherapy on the Risk of Developing Secondary Malignant Neoplasms in Hodgkin's Lymphoma Survivors

  • Abou-Antoun, Tamara;Mikhael, Rachelle;Massoud, Marcel;Chahine, Georges;Saad, Aline
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제17권2호
    • /
    • pp.749-754
    • /
    • 2016
  • Extended follow-up of Hodgkin lymphoma (HL) survivors indicates that these patients are at high risk of secondary malignant neoplasms (SMNs) contributing to increased morbidity and mortality. This study examined the characteristics of HL survivors who developed SMNs with the aim to report any correlation with radiotherapy (RT) dose. In this retrospective multi-center cohort study of HL patients treated between 1990 and 2011 at three major teaching hospitals in Lebanon, classification was into two groups including those treated with combined modality (RT and chemotherapy-CHT) and those treated with CHT alone. Approval from the University Institutional Review Board (IRB) was obtained. Of the 112 patients evaluated, 52.7% (59) received the combined modality while 47.3% (53) received CHT alone. There were 6 cases of SMNs in the combined modality cohort and 5 cases in the CHT cohort. The mean RT dose in the combined modality cohort was 34.5 Gray (Gy) ($SD{\pm}5.3$). A statistically significant increase (1.5 fold) in the risk of developing SMNs was observed among patients who received a dose higher than 41 Gy compared to a dose between 20 to 30 Gy (OR= 1.5; 95% confidence interval= 0.674 to 3.339, p=0.012). The risk of SMNs was not significantly higher among patients who received extended field compared to involved field RT (p=0.964). This study showed that the risk of developing SMNs is higher among patients treated with RT dose greater than 31 Gy, independent of the RT type used.

Simultaneous Development of Three Different Neoplasms of Trichilemmoma, Desmoplastic Trichilemmoma and Basal Cell Carcinoma Arising from Nevus Sebaceus

  • Lee, Chi An;Kang, Seok Joo;Jeon, Seong Pin;Sun, Hook;Kang, Mi Seon
    • 대한두개안면성형외과학회지
    • /
    • 제18권1호
    • /
    • pp.46-49
    • /
    • 2017
  • Nevus sebaceus is a hamartoma of the sebaceous gland that occurs congenitally, from which various secondary tumors can arise with a prevalence of 5%-6%. Benign neoplasms commonly arise from nevus sebaceous, but they have a very low malignant potential. Two neoplasms may occasionally arise within the same lesion, but it is rare for three or more neoplasms to occur in a nevus sebaceus simultaneously. A 61-year-old male patient was admitted to our hospital for a $4cm\times2.5cm$ growing tumor in a verrucous form arising within a periauricular nevus sebaceus in the post auricle of the left ear that had developed 30 years earlier. The nodule was diagnosed as 3 different types of tumors: trichilemmoma, desmoplastic trichilemmoma, and basal cell carcinoma. To our knowledge, this is the first report of the coexistence of three different tumors arising from nevus sebaceous. It contain malignant neoplasm also. Surgeons should be aware of the need for close monitoring and early complete surgical excision of sebaceous nevus in order to improve patient outcomes.

개의 Intraocular Lymphoma (Intraocular Lymphoma in a Dog)

  • 우흥명
    • 한국임상수의학회지
    • /
    • 제18권4호
    • /
    • pp.429-433
    • /
    • 2001
  • 림프종은 임상에서 많이 발생되는 개의 악성 종양이지만, 눈 안에서의 발생은 그 예가 드물다. 본 연구는, 수정체낭의 혼탁, 초자체 출혈, 전신적인 임파선증 및 복부중앙의 응괴가 관찰되는 8년령 잡종견에서 병력, 임상증상, 방사선 검사, 세포 및 조직병리학 검사, 화학요법에 의한 반응을 통하여 속발성 안내 염증을 동반하는 전신적인 다발성 lymphoma를 확진하는 방법을 알아보았다. 개의 눈 안에서 관찰되는 속발성 lymphoma는 전신적인 lymphoma를 예견하는 중요한 임상소견이 될 수 있으므로 수의 임상에 응용이 가능하리라 판단된다.

  • PDF

Surgical Outcomes of Malignant Primary Cardiac Tumor: A 20-Year Study at a Single Center

  • Ryu, Seung Woo;Jeon, Bo Bae;Kim, Ho Jin;Kim, Joon Bum;Jung, Sung-Ho;Choo, Suk Jung;Chung, Cheol Hyun;Lee, Jae Won
    • Journal of Chest Surgery
    • /
    • 제53권6호
    • /
    • pp.361-367
    • /
    • 2020
  • Background: Malignant primary cardiac tumors are extremely rare, but have a poor prognosis. This study evaluated the surgical outcomes of patients with this disease. Methods: Forty patients who underwent surgery for malignant primary cardiac tumors between January 1998 and December 2018 were enrolled. Participants were divided into 3 groups based on resection margins (R0, 14 patients; R1, 11 patients; and R2, 11 patients) and their surgical outcomes were compared. Heart transplantation was performed in 4 patients with unresectable tumors. Results: Early mortality was reported in 2 cases (5%) due to postoperative bleeding and cerebral hemorrhage secondary to brain metastasis. The 1- and 2-year survival rates were 67.5% and 42.5%, respectively. The median survival time of the patients was 20.3 months (range, 9.2-37.6 months). The median survival time was 48.7, 20.3, and 4.8 months in patients with R0, R1, and R2 resections, respectively (p=0.023). Tumor recurrence occurred in 21 patients (61.7%), including 4 cases of local recurrence and 17 cases of distant metastasis. In patients who underwent heart transplantation, the median survival time was 29.5 months, with 3 cases of distant metastasis. Conclusion: Although surgery for malignant primary cardiac tumors has a poor prognosis, complete resection of the tumor may improve surgical outcomes.

Growth hormone treatment and risk of malig­nancy

  • Chae, Hyun-Wook;Kim, Duk-Hee;Kim, Ho-Seong
    • Clinical and Experimental Pediatrics
    • /
    • 제58권2호
    • /
    • pp.41-46
    • /
    • 2015
  • Growth hormone (GH) treatment has been increasingly widely used for children with GH deficiencies as the survival rate of pediatric patients with malignancies has increased. Both GH and insulin-like growth factor-I have mitogenic and antiapoptotic activity, prompting concern that GH treatment may be associated with tumor development. In this review, the authors examined the relationship between GH treatment and cancer risk in terms of de novo malignancy, recurrence, and secondary neoplasm. Although the results from numerous studies were not entirely consistent, this review of various clinical and epidemiological studies demonstrated that there is no clear evidence of a causal relationship between GH treatment and tumor development. Nonetheless, a small number of studies reported that childhood cancer survivors who receive GH treatment have a small increased risk of developing de novo cancer and secondary malignant neoplasm. Therefore, regular follow-ups and careful examination for development of cancer should be required in children who receive GH treatment. Continued surveillance for an extended period is essential for monitoring long-term safety.

뼈 전이로 오인될 수 있는 흉강 외 악성 종양으로 인한 비대성 골관절증의 초기 영상 소견 (Early Imaging Findings of Hypertrophic Osteoarthropathy Mimicking Bone Metastasis from Extrathoracic Malignancy)

  • 황지연;차장규;윤유성;문아림
    • 대한영상의학회지
    • /
    • 제82권6호
    • /
    • pp.1606-1612
    • /
    • 2021
  • 비대성 골관절증은 곤봉지, 근막골형성 및 윤활막 삼출액을 특징으로 하는 증후군이다. 이차성 비대성 골관절증은 대부분의 경우 흉부 내 악성 종양과 연관이 있으나, 드물게 흉강 외 악성 종양에 의해 발생할 수 있다. 이에 우리는 유방암의 과거력이 있는 환자에서 발생한 비대성 골관절증의 초음파, 전산화단층촬영, 자기공명영상 및 뼈 신티그래피의 초기 영상의학적 소견에 대해 서술하고자 한다. 악성 종양으로 오인된 본 증례의 모호한 임상 및 영상 소견은 독자에게 흥미롭고 유익할 것으로 생각된다.

방광에 발생한 원발성 소세포암종의 세포학적 소견 -1 예 보고- (Cytologic Findings of Primary Small Cell Carcinoma of the Urinary Bladder - A case report -)

  • 권미선;안긍환;정진행;이승숙;고재수
    • 대한세포병리학회지
    • /
    • 제12권2호
    • /
    • pp.121-125
    • /
    • 2001
  • Primary small cell carcinoma of the urinary bladder is a rare malignant tumor. A more rapidly fatal course may be seen in advanced stages of small cell carcinoma as compared to similar stages of urothelial carcinoma. It is very important to recognize this distinct form of bladder cancer by urinary cytology The differential diagnosis of small cell carcinoma of the urinary bladder includes metastatic small cell carcinoma, urothelial carcinoma, and primary or secondary malignant lymphoma. This article highlights the urinary cytologic diagnosis of a case of primary small cell carcinoma. A 59-year-old male presented with gross hematuria for five months. Urinary cytology showed high cellularity consisting of tiny monotonous tumor cells in the necrotic background. The tumor cells occurred predominantly singly, but a few in clusters. The cytoplasm was so scanty that only a very narrow rim of it was seen. The nuclei were oval or round and had finely stippled chromatin. Rarely, the nuclei contain visible nucleoli. Frequently cell molding was noted in clusters. Many single cells demonstrated nuclear pyknosis or karyorrhexis. The histologic findings of transurethral resection and partial cystectomy specimen were those of small cell carcinoma. Cytologic distinction may be very difficult but careful attention to clinical features and cellualr details can classify these neoplasms correctly.

  • PDF

피지선 모반에서 동시에 발생한 편평세포암과 기저세포암 (Squamous Cell Carcinoma and Basal Cell Carcinoma Simultaneously Arising in a Nevus Sebaceus: A Case Report)

  • 박현민;이동근;신경진;윤태영;이지연;성노현;송형근;이동욱;이의태
    • Archives of Plastic Surgery
    • /
    • 제38권6호
    • /
    • pp.883-885
    • /
    • 2011
  • Purpose: Nevus sebaceus is a congenital hamartomatous lesion, typically involving head and neck. Various benign and malignant neoplasms can develop in association with nevus sebaceus. We report a case of simultaneous occurrence of squamous cell carcinoma and basal cell carcinoma in nevus sebaceus. Methods: A 73-year-old man presented with erythematous to black verrucous nodules on the right subauricular area. The upper part was accompanied with inflammation and ulceration, and no specific findings suspicious for malignant degeneration were found in the lower part preoperatively. The mass was totally excised and the defect was directly closed. Lymph nodes were not involved on concomitant neck dissection. Results: Histopathologic examination confirmed the presence of squamous cell carcinoma in the upper part and basal cell carcinoma in the lower part of a nevus sebaceus. Negative margins were achieved on resection. No clinical problems were found during the 3-month follow-up period. Conclusion: We experienced a rare case of simultaneous occurrence of squamous cell carcinoma and basal cell carcinoma within the same nevus sebaceus. Because patients with nevus sebaceus have risk of malignant changes, surgical excision and work-up for recurrence and metastasis should be considered in suspicious cases. And even in a totally asymptomatic case, the possibility of occult secondary cancer should be informed before surgery in aged patients.

IMRT에 있어 Jaw Tracking 의 임상적 유용성 검증 (Verification of Clinical Usefulness of Jaw Tracking in IMRT)

  • 김진영;김기환
    • 한국방사선학회논문지
    • /
    • 제14권2호
    • /
    • pp.105-109
    • /
    • 2020
  • 세기조절방사선치료(IMRT)는 치료범위의 선량분포를 향상시키고 주변 정상조직을 보호한다는 점에서 두경부, 전립선, 뇌와 같은 부위에 널리 사용되고 있다. 그러나 이러한 세기조절방사선치료는 입체조형방사선치료에 비해 많은 방사선조사량으로 인해 누적선량이 증가하고 다엽콜리메이터의 누설선량이나 투과선량으로 인한 저선량이 증가하는 양상을 보인다. 이러한 누적선량이나 저선량의 증가는 악성 종양의 재발생율을 증가시키는 것으로 보고되고 있다. 본 논문에서는 뇌종양의 방사선치료에 있어 기존 선형가속기의 단점을 보완하고 다엽콜리메이터의 누설선량이나 투과선량을 줄이기 위해 개발된 Varian사의 TRUEBEAM 의 Jaw Tracking 기능의 임상적인 유용성을 검증하고자 하였다. Jaw tracking 기능의 임상적 유용성을 검증하기 위해 Varian사의 Eclipse11을 이용하여 치료범위에서 1) Organ At Risk(OAR)에 2 cm 이상 떨어진 경우 2) OAR에 2 cm 이하로 떨어진 경우 3) OAR를 포함하는 경우 3 가지의 원본 치료계획을 만들고 이를 복사한 후, Smart LMC Version 11.0.31을 이용하여 Jaw tracking 기능을 사용한 치료계획을 만들었다. 비교는 두 치료계획 간의 Cumulative Dose Volume Histogram(DVH) 에서 OAR의 평균선량 및 최대선량의 차이를 통해 평가하였다. 두 치료계획 간의 DVH 비교 결과 PTV가 OAR에 2 cm 이상 떨어진 경우 두 치료계획 간의 차는 최대 0.5 % 차이, 2 cm 이하로 떨어진 경우 최대 0.6 % 차이, PTV가 OAR을 포함하는 경우 최대 2.3 % 차이를 가졌다. 이 결과에 의하면 OAR과 PTV 간의 거리가 가까워짐에 따라 인접해있는 OAR 평균선량 및 최대선량에 있어 두 치료계획간 차가 커짐을 알 수 있다. 따라서 Jaw Tracking을 사용한 경우 일관성 있게 선량 감소가 있고 표면선량이 증가하지 않으므로 임상적인 유용성을 검증할 수 있었다. 향후 본 연구결과를 토대로 뇌, 두경부, 전립선과 같은 부위에 방사선 치료 시 선량감소 정도에 대한 추가 연구를 진행하여 각 부위에 따른 Jaw Tracking의 임상적 유용성 검증이 가능할 것으로 사료된다.